List of Articles
Kawasaki Disease. Vol. 3, No. 2, 2025
Review
Scoping Review of Kawasaki Disease Research Using National Databases in Korea
Kawasaki Dis 2025;3(2):e10
https://doi.org/10.59492/kd.2025.3.2.e10
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e10
Treatment of Acute Stage of Kawasaki Disease Based on Updated 2024 Guidelines from the American Heart Association
2024 AHA 개정 지침 근거 가와사끼병의 급성기 치료
2024 AHA 개정 지침 근거 가와사끼병의 급성기 치료
Kawasaki Dis 2025;3(2):e11
https://doi.org/10.59492/kd.2025.3.2.e11
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e11
Thrombosis in Kawasaki Disease: Implications for Coronary Artery Aneurysm Risk, Diagnosis, and Anti-Thrombotic Management
Kawasaki Dis 2025;3(2):e12
https://doi.org/10.59492/kd.2025.3.2.e12
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e12
Catheter-Based Revascularization and Antithrombotic Strategies for Post-Kawasaki Disease Coronary Artery Lesions: A Narrative Review of Guideline-Aligned Management
가와사키병에서 관상동맥 병변의 중재술 및 항혈전 전략: 지침 기반 관리
가와사키병에서 관상동맥 병변의 중재술 및 항혈전 전략: 지침 기반 관리
Kawasaki Dis 2025;3(2):e13
https://doi.org/10.59492/kd.2025.3.2.e13
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e13
Coronary Intervention in Kawasaki Disease
Kawasaki Dis 2025;3(2):e14
https://doi.org/10.59492/kd.2025.3.2.e14
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e14
Vaccination in Children with Kawasaki Disease Treated with Biological Drugs
생물학적 제제 치료를 받은 가와사키병 소아의 예방접종
생물학적 제제 치료를 받은 가와사키병 소아의 예방접종
Kawasaki Dis 2025;3(2):e15
https://doi.org/10.59492/kd.2025.3.2.e15
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e15
Original Article
Nationwide Validation of Japanese Initial Intravenous Immunoglobulin (IVIG) Resistance Scores in Korean Children with Kawasaki Disease
Kawasaki Dis 2025;3(2):e16
https://doi.org/10.59492/kd.2025.3.2.e16
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e16
Toward Integrated Use of BNP and N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP) in Predicting Resistance to Initial Intravenous Immunoglobulin (IVIG) in Acute Phase of Kawasaki Disease
Kawasaki Dis 2025;3(2):e17
https://doi.org/10.59492/kd.2025.3.2.e17
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e17
Comparison of Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease
소아다기관염증증후군과 가와사키병의 비교
소아다기관염증증후군과 가와사키병의 비교
Kawasaki Dis 2025;3(2):e18
https://doi.org/10.59492/kd.2025.3.2.e18
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e18
Case Report
Pathophysiological Connection between MIS-C Following SARS-CoV-2 Infection and Kawasaki Disease: The Role of ACE2 Expression
Kawasaki Dis 2025;3(2):e19
https://doi.org/10.59492/kd.2025.3.2.e19
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e19
Atypical Manifestation of Kawasaki Disease Presenting as Acalculous Cholecystitis
Kawasaki Dis 2025;3(2):e20
https://doi.org/10.59492/kd.2025.3.2.e20
HTML
PDF
PubReader
TDM
https://doi.org/10.59492/kd.2025.3.2.e20






